Skip to main content
. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662

Figure 6.

Figure 6

Chemical structure of several CF transmembrane conductance regulator (CFTR) modulators tested in clinical trials or currently in the market. Advances in high-throughput screening technologies have been enabling the identification of small-molecules from different chemical series. In addition to the compounds displayed in this figure, the compounds VX-121, ABBV-2737, ABBV-3067, FDL176, and PTI-808 are also under investigation in clinical trials, but the chemical structures are still not available on the PubChem or DrugBank. *Clinical development has been discontinued.